Stonvex
Stonvex
StonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $18.86 | $18.84 | -0.08% | 0.0M |
| 05-12 | $18.84 | $18.86 | +0.11% | 0.0M |
| 05-13 | $18.87 | $18.86 | -0.05% | 0.0M |
| 05-14 | $18.87 | $18.86 | -0.05% | 0.0M |
| 05-15 | $18.86 | $18.86 | +0.00% | 0.0M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $78.06M | $51.59M | $26.04M | $104.35M |
Operating Income | $9.94M | $7.12M | $3.68M | $13.78M |
Net Income | $5.96M | $4.32M | $2.26M | $8.33M |
EPS (Diluted) | $0.87 | $0.63 | $0.33 | $1.21 |
Total Assets | $219.22M | $217.22M | $218.35M | $216.91M |
Total Liabilities | $54.77M | $54.36M | $56.96M | $56.80M |
Cash & Equivalents | $53.65M | $52.98M | $54.28M | $56.33M |
Free Cash Flow OCF − CapEx | $1.00M | $-404.00K | $-177.00K | $7.47M |
Shares Outstanding | 6.87M | 6.87M | 6.87M | Not available |
No sell-side coverage available for FONR.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.